Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Pyoderma gangrenosum, acne, psoriasis, arthritis and suppurative hidradenitis (PAPASH)-syndrome: a new entity within the spectrum of autoinflammatory syndromes?

Garzorz N, Papanagiotou V, Atenhan A, Andres C, Eyerich S, Eyerich K, Ring J, Brockow K.

J Eur Acad Dermatol Venereol. 2016 Jan;30(1):141-3. doi: 10.1111/jdv.12631. Epub 2014 Jul 28. No abstract available.

PMID:
25070077
2.
3.

Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)--a new autoinflammatory syndrome distinct from PAPA syndrome.

Braun-Falco M, Kovnerystyy O, Lohse P, Ruzicka T.

J Am Acad Dermatol. 2012 Mar;66(3):409-15. doi: 10.1016/j.jaad.2010.12.025. Epub 2011 Jul 13.

PMID:
21745697
5.

Remission of refractory pyoderma gangrenosum, severe acne, and hidradenitis suppurativa (PASH) syndrome using targeted antibiotic therapy in 4 patients.

Join-Lambert O, Duchatelet S, Delage M, Miskinyte S, Coignard H, Lemarchand N, Alemy-Carreau M, Lortholary O, Nassif X, Hovnanian A, Nassif A.

J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S66-9. doi: 10.1016/j.jaad.2015.07.040.

PMID:
26470620
6.

PsAPASH: a new syndrome associated with hidradenitis suppurativa with response to tumor necrosis factor inhibition.

Saraceno R, Babino G, Chiricozzi A, Zangrilli A, Chimenti S.

J Am Acad Dermatol. 2015 Jan;72(1):e42-4. doi: 10.1016/j.jaad.2014.10.002. No abstract available.

8.

PASS Syndrome: An IL-1-Driven Autoinflammatory Disease.

Leuenberger M, Berner J, Di Lucca J, Fischer L, Kaparos N, Conrad C, Hohl D, So A, Gilliet M.

Dermatology. 2016;232(2):254-8. doi: 10.1159/000443648. Epub 2016 Feb 27.

PMID:
26919742
9.

Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene.

Marzano AV, Trevisan V, Gattorno M, Ceccherini I, De Simone C, Crosti C.

JAMA Dermatol. 2013 Jun;149(6):762-4. doi: 10.1001/jamadermatol.2013.2907. No abstract available.

PMID:
23571383
10.

Successful use of adalimumab to treat pyoderma gangrenosum, acne and suppurative hidradenitis (PASH syndrome) following colectomy in ulcerative colitis.

Murphy B, Morrison G, Podmore P.

Int J Colorectal Dis. 2015 Aug;30(8):1139-40. doi: 10.1007/s00384-014-2110-9. Epub 2015 Jan 7. No abstract available.

PMID:
25564349
11.

Pyoderma gangrenosum, acne and suppurative hidradenitis syndrome following bowel bypass surgery.

Marzano AV, Ishak RS, Colombo A, Caroli F, Crosti C.

Dermatology. 2012;225(3):215-9. doi: 10.1159/000343602. Epub 2012 Nov 16.

PMID:
23171584
12.

Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone.

Staub J, Pfannschmidt N, Strohal R, Braun-Falco M, Lohse P, Goerdt S, Leverkus M.

J Eur Acad Dermatol Venereol. 2015 Nov;29(11):2243-7. doi: 10.1111/jdv.12765. Epub 2014 Oct 28. Review.

PMID:
25352307
13.

First nicastrin mutation in PASH (pyoderma gangrenosum, acne and suppurative hidradenitis) syndrome.

Duchatelet S, Miskinyte S, Join-Lambert O, Ungeheuer MN, Francès C, Nassif A, Hovnanian A.

Br J Dermatol. 2015 Aug;173(2):610-2. doi: 10.1111/bjd.13668. Epub 2015 Jun 11. No abstract available.

PMID:
25601011
14.

Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis.

Scheinfeld N.

Dermatol Online J. 2013 Jun 15;19(6):18558. Review.

15.

Association of pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) shares genetic and cytokine profiles with other autoinflammatory diseases.

Marzano AV, Ceccherini I, Gattorno M, Fanoni D, Caroli F, Rusmini M, Grossi A, De Simone C, Borghi OM, Meroni PL, Crosti C, Cugno M.

Medicine (Baltimore). 2014 Dec;93(27):e187. doi: 10.1097/MD.0000000000000187. Erratum in: Medicine (Baltimore). 2015 Feb;94(8):1. Medicine (Baltimore). 2015 Feb;94(8):1. Medicine (Baltimore). 2015 Apr;94(15):1.

16.

Autoinflammatory syndromes associated with hidradenitis suppurativa and/or acne.

Vinkel C, Thomsen SF.

Int J Dermatol. 2017 Mar 27. doi: 10.1111/ijd.13603. [Epub ahead of print] Review.

PMID:
28345207
17.

Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne).

Demidowich AP, Freeman AF, Kuhns DB, Aksentijevich I, Gallin JI, Turner ML, Kastner DL, Holland SM.

Arthritis Rheum. 2012 Jun;64(6):2022-7. doi: 10.1002/art.34332. Epub 2011 Dec 12.

18.

Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra.

Brenner M, Ruzicka T, Plewig G, Thomas P, Herzer P.

Br J Dermatol. 2009 Nov;161(5):1199-201. doi: 10.1111/j.1365-2133.2009.09404.x. Epub 2009 Aug 10.

PMID:
19673875
19.

Pyoderma gangrenosum, acne, and hidradenitis suppurativa (PASH) syndrome with recurrent vasculitis.

Niv D, Ramirez JA, Fivenson DP.

JAAD Case Rep. 2017 Feb 4;3(1):70-73. doi: 10.1016/j.jdcr.2016.11.006. eCollection 2017 Jan. No abstract available.

20.

Systematic review of the efficacy and adverse events associated with infliximab treatment of hidradenitis suppurativa in patients with coexistent inflammatory diseases.

Machet L, Samimi M, Delage M, Paintaud G, Maruani A.

J Am Acad Dermatol. 2013 Oct;69(4):649-50. doi: 10.1016/j.jaad.2013.04.032. Review. No abstract available.

PMID:
24034373

Supplemental Content

Support Center